Fraxiparine

Fraxiparine is a medication containing Nadroparin Calcium, used for anticoagulation. It is commonly administered via subcutaneous or intravenous routes, including during haemodialysis. This product is manufactured by Viatris Sia in the EU.

Fraxiparine is primarily used for anticoagulation, helping to prevent blood clots. It is often utilized in medical settings for patients undergoing haemodialysis or those at risk of thromboembolic events. The medication works by inhibiting certain clotting factors in the blood, promoting smoother blood flow.

Common effects of Fraxiparine may include bruising, bleeding, and irritation at the injection site. Some users might experience allergic reactions, though these are less frequent. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Fraxiparine should be handled with care, especially by individuals with a history of bleeding disorders or recent surgeries. It is crucial to follow the prescribed administration route, whether subcutaneous or intravenous, to minimize risks. Always store the medication as directed to maintain its efficacy.

Fraxiparine may interact with other anticoagulants, antiplatelet drugs, and certain pain relievers. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always inform healthcare providers about all medications being taken to avoid potential interactions.